Use of sodium iodide symporter expression in differentiated thyroid carcinomas (2011)
Source: Clinical Endocrinology. Unidade: FO
Subjects: SÓDIO, IODO, CARCINOMA, DOENÇAS DA TIREOIDE, ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORARI, Elaine C et al. Use of sodium iodide symporter expression in differentiated thyroid carcinomas. Clinical Endocrinology, p. 247-254, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2011.04032.x. Acesso em: 14 nov. 2024.APA
Morari, E. C., Marcello, M. A., Guilhen, A. C. T., Cunha, L. L., Latuff, P., Soares, F. A., et al. (2011). Use of sodium iodide symporter expression in differentiated thyroid carcinomas. Clinical Endocrinology, 247-254. doi:10.1111/j.1365-2265.2011.04032.xNLM
Morari EC, Marcello MA, Guilhen ACT, Cunha LL, Latuff P, Soares FA, Ward LS, Vassallo J. Use of sodium iodide symporter expression in differentiated thyroid carcinomas [Internet]. Clinical Endocrinology. 2011 ; 247-254.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1111/j.1365-2265.2011.04032.xVancouver
Morari EC, Marcello MA, Guilhen ACT, Cunha LL, Latuff P, Soares FA, Ward LS, Vassallo J. Use of sodium iodide symporter expression in differentiated thyroid carcinomas [Internet]. Clinical Endocrinology. 2011 ; 247-254.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1111/j.1365-2265.2011.04032.x
